Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: bob zagorin who wrote (293)	10/23/2003 8:32:47 PM
From: Miljenko Zuanic	of 590

Note from CC; 1. They are expecting to start pivotal third line (single agent?) CRC by year-end/early 2004. This is too optimistic. Due to manufacturing issue, imo. 2. EGFr-mutant not included in AZ deal. First candidate to be selected somewhere in '06. 3. Front line CRC now with FOL-FOX, instead of the Saltz as did started. 4. CRGN already selected four targets. How many are left? Do your HW and DD, and do not ask too many questions. Miljenko [eom]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next